Tom Polen’s Post

Even though M&A activity decreased by 29% in Q1 2024 compared with the previous quarter, M&A is still a major way the Medical Devices space changes year on year. The critical care medical devices industry was valued at USD 31.60 Billion in 2023.

MedTech News💡 BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader! MedTech at it again! & Certainly one to keep on eye on! For me it will be interesting to see how both companies are going to be impacted by this.🧠 #medtechnews#medtech#medicaldevices

Contact: Fred Pira President & CEO ProNex Inc. 847-726-7718 office 847-778-8336 mobile [email protected] ProNex, Inc. Unveils CORE®LMP: A Cutting-Edge Digital Solution for Comprehensive Lifestyle Medicine Care ProNex is excited to introduce CORE®LMP, an innovative digital platform designed to revolutionize patient care by seamlessly integrating lifestyle medicine into healthcare practices. Key Features of the CORE® Platform: Seamless Patient Connectivity: Effortlessly connect with patients through existing Electronic Medical Record (EMR) systems. Comprehensive Lifestyle Assessment: Utilize the ACLM lifestyle assessment form, with culturally adapted versions for diverse patient needs. Automated Content Delivery: Provide culturally adapted lifestyle medicine content, including ACLM videos and handouts and/or your own content, to keep patients motivated. Engagement and Outcome Tracking: Monitor patient engagement and document clinical and behavioral outcomes efficiently. Reimbursement Documentation: Easily document outcomes and compliance for reimbursement, adding value and saving time. HIPAA Compliant: Track patient communication, education, and compliance with the six core pillars of Lifestyle Medicine in a HIPAA-compliant environment. The CORE® platform’s interoperability with existing EMR systems allows providers to instantly deliver lifestyle medicine to any patient population, enhancing care and improving outcomes. ProNex, Inc. is led by industry veterans with a proven track record of helping healthcare organizations deliver complex patient care workflows efficiently. These innovative solutions have consistently saved time and money, reduced provider burnout, and boosted profitability. ProNex, Inc. – Innovating Healthcare, Simplifying Care.

Explore the future of value creation in MedTech! Discover key strategies and best practices for navigating the shift in value delivery to customers and patients. Read the full article: https://lnkd.in/epiStJst #MedTech #HealthcareInnovation #ValueBasedCare #HealthTech

Engaging patients isn't just a trend - it's a fundamental shift in how successful MedTech companies approach innovation. We understand that patient engagement is the key to not only improving outcomes but also ensuring that your medical technology meets the real-world needs of those it serves. By making patients an integral part of the development process, you’re not just creating a product - you’re creating a solution that truly resonates. 📈 Why Patient Engagement Matters Patient engagement is more than just a buzzword—it's a critical component of successful medtech innovation. When patients are actively involved in their own healthcare, the results speak for themselves: improved adherence to treatment plans, better health outcomes, and enhanced patient satisfaction. Engaged patients are more likely to take ownership of their health, leading to more meaningful interactions with healthcare providers and ultimately, better results. 🌟 Enhancing Your Medtech Success For medtech companies, integrating patient engagement into the development and commercialization process is essential. Engaged patients provide invaluable feedback that can guide product design, influence clinical trial outcomes, and ensure that the final product truly meets the needs of those it serves. This proactive involvement not only fosters trust but also enhances the likelihood of regulatory approval and market success. 🤝 Building Trust and Compliance Patient engagement is also key to fostering trust and compliance. By involving patients early in the process and throughout the lifecycle of the medical device, you build a sense of ownership and partnership. This trust translates into higher compliance rates, better data collection, and a smoother path to market adoption. 🚀 Partner with Us for Optimal Engagement At TTi Health Research & Economics, we specialize in crafting tailored patient engagement strategies that align with your device's goals. Whether it's designing user-friendly interfaces, incorporating patient feedback into product development, or conducting studies that focus on patient-centered outcomes, our expertise ensures that your medtech innovation resonates with its end users. Don’t leave patient engagement to chance. By partnering with us, you’re taking a strategic step toward ensuring your MedTech solution not only reaches the market but also thrives in it. Let’s collaborate to create a patient engagement strategy that sets your device apart and drives lasting success. Have questions? 📆 Schedule an initial call with our VP of Client Relations, Fernanda Nusbaum https://lnkd.in/ekuUHWFc 📰 TTi's newsletter: Sign up and share with your coworkers! https://zurl.co/tOHc #MedTech #CRO #ClinicalResearch #Research #Clinical #StudyManagement #Study #RiskManagement #ValidationStudies #Data #Innovation #MedDevice #EvGen #Evidence #Reimbursement #HECON #HealthEconomics 

BD acquiring the previously announced spin-off of Edwards' critical care business. Quick thoughts: - $4.2B cash. Biggest deal since Bard. Separate BU within BD Medical. - Good fit with wider connected care strategy - Edwards Hemosphere is 'modern' monitoring platform w/ machine learning, range of sensors - Aligns with need for integrated systems to reduce cognitive load and labor costs in hospital - Brings more complex disposables to BD (e.g. blood pressure fingure cuff) - Challenges coming up will no doubt be software integration and product rationalization; approvals for, adoption of any AI tools. To what extent do they combine Alaris and Hemosphere monitoring technologies?

With the LatAm MedTech market experiencing massive growth (valued at $10B with 2.3% growth YoY) and representing a $2.7B opportunity for exporters, it's an important time to understand your organizations potential in the 5 countries representing 90% of the market. Partnering with GHI, Clarivate can help you identify which hospitals have the highest procedural volumes and how your competitors are performing. Heart valves, infusion pumps, and neuro accessories are some of the highest growth markets, but aren't the only segments experiencing a boom - I'd love to understand how your organization is preparing to increase shares in the region? #MedTech #LATAM #Clarivate

An overview of NHS England’s proposal for a more integrated #MedTech pathway includes detailed plans for both streamlined processes and a lifecycle approach https://lnkd.in/e7VS7wXR Streamlined Processes ⏩ : - Clearer Signals to Industry 🚦 : Providing clearer indications of the innovations needed by patients, which will help guide MedTech development. - Regulatory Framework Reform 📰 : Reforming the regulatory environment for medical devices to facilitate innovation. - Expanded Product Assessments ✅ : Broadening the scope of product categories assessed, ensuring a wider range of MedTech is evaluated for NHS use. - Funding Clarity 💰 : Improving transparency over funding routes to ease the financial aspects of MedTech integration. - Procurement as an Enabler 🎣 : Making procurement a supportive process for innovation rather than a hindrance. Lifecycle Approach ☯ : - Early-Stage Support 🐣 : Assisting early-stage technologies with additional evidence generation to validate their effectiveness and efficiency. - NICE Assessment Readiness 🏇 : Preparing groups of new, cutting-edge technologies for NICE assessments to determine their clinical and cost-effectiveness. - Value-Driven Existing Technology 🥇 : Focusing on existing technologies already in use within the NHS to maximize their value and impact on patient care. These proposals are designed to create a more predictable and supportive system for the development and integration of MedTech into the NHS, ultimately ensuring that patients have faster access to effective medical technologies.

Aditya Kohli, CFO & Director, Allied Medical Limited, writes about the global landscape, healthcare innovation, market dynamics, and challenges in the Laboratory Special edition of Medical Buyer. #healthcare #innovation #market #dynamics #landscape #trends market #adaptation #medical #technology #industry #business #devices #environment #advertorial

With a surge in market value, the LatAm medical equipment and device markets have seen substantial growth, currently valued at $10 billion annually. Underscoring its pivotal role in the healthcare industry, this reflects the increasing demand for cutting-edge medical technologies and the region’s continuous commitment to enhancing healthcare infrastructure and accessibility. Clarivate has launched LatAm marketing tracking solution in partnership with Global Health Intelligence, providing medical device companies and distributors with valuable insights into the region's market share dynamics, helping them understand where they are gaining or losing share, identifying competitors in specific regions, and discerning the brands that are influencing these trends. Read the full press release here: https://lnkd.in/gMvmPAze #LATAM #MedTech #Healthcare #Thinkforward